The cause of type 1 diabetes remains unknown and is a ... Identifying the presence of the peptide is a significant step, said Altindis, who collaborated on the project with C. Ronald Kahn, MD, of the ...

Medically reviewed by Isabel Casimiro, MD, PhD Type 1.5 diabetes is a controversial diagnosis that combines features of the ...

Type 1 diabetes is an immune-mediated disease in ... remaining beta-cell mass as assessed by C peptide (a cleavage product generated and measurable in peripheral blood during insulin production ...

Cour Pharmaceuticals Development Co. Inc. has obtained IND clearance from the FDA for CNP-103, a nanoparticle in development to address the underlying autoimmunity of type 1 diabetes. A first-in-human ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

The surge followed highly positive analyst reactions to initial data from a groundbreaking type 1 diabetes trial using ... evidenced by circulating C-peptide levels, which indicate insulin production.

Of the two well-known rodent models of human type 1 diabetes (the non-obese diabetic ... genes and identification of cognate peptide(s) were predicted to follow. From there, identification of ...

Non-insulin glucose-lowering treatments may initially work for type 1.5 diabetes but become ineffective once beta-cell function drastically declines. C-peptide tests (a standard diagnostic tool ...